Hearing on "Negotiating a Better Deal: Legislation to Lower the Cost of Prescription Drugs"
The Subcommittee on Health of the Committee on Energy and Commerce held a legislative hearing on Tuesday, May 4, at 11:30 a.m. via Cisco WebEx. The hearing is entitled, "Negotiating a Better Deal: Legislation to Lower the Cost of Prescription Drugs."
Memorandum from Chairman Pallone to the Subcommittee on Health
Opening Statement from Chairman Pallone as prepared for delivery
Opening Statement from Subcommittee Chairwoman Eshoo as prepared for delivery
H.R. 3, the "Elijah E. Cummings Lower Drug Costs Now Act"
H.R. 19, the "Lower Costs, More Cures Act of 2021"
H.R. 153, the "Protecting Consumer Access to Generic Drugs Act of 2021"
H.R. 2815, the "Bolstering Innovative Options to Save Immediately on Medicines Act" or the "BIOSIM Act"
H.R. 2831, the "Prompt Approval of Safe Generic Drugs Act"
H.R. 2843, the "Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon Act of 2021" or the "STOP GAMES Act"
H.R. 2846, to amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of hte Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes
H.R. 2853, the "Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2021" or the "BLOCKING Act"
Michael A. Carrier
Distinguished Professor of Law
Rutgers Law School
Associate Professor of Law
Washington University in St. Louis, School of Law
Gaurav Gupta, M.D., M.S.E.
Khrystal K. Davis, J.D.
Rare Disease Caregiver & Patient Advocate
Texas Rare Alliance Founding President